How The 5 Cannabis Categories Performanced Last Week

The 5 categories in the cannabis sector perform quite differently from each other on a weekly basis. Last week, their stock performance ranged from -2.9% To +12.0%.

The 5 categories in the cannabis sector perform quite differently from each other on a weekly basis and below is a summary of how each category  performed last week, in descending order, and YTD:

  1. The Ancillary Pot Stock IndexUP 12.0% last week; UP 16.8% YTD
    • The Index consists of the 7 largest companies providing goods and services to the cannabis sector, namely, AFC Gamma  (AFCG); Forian (FORA);  Hydrofarm (HYFM); GrowGeneration (GRWG); Innovative Industrial Properties (IIPR);  Scotts Miracle-Gro Company (SMG) and Turning Point Brands (TPB) which trade for at least US$3/share on the Canadian and/or American stock exchanges and have a market cap of at least US$100M.
  2. The American Cannabis MSOs Index: UP 7.3% last week; UP 2.0% YTD
  3. The Conservative Pot Stocks Index: UP 1.8% last week; UP 0.1% YTD
    • The Index consists of 6 tobacco, beer, and liquor companies that have invested heavily in the cannabis industry, namely, Altria Group (MO); Anheuser-Busch  (BUD); British American Tobacco (BTI); Constellation Brands (STZ);  Imperial Brands (IMBBY) and Molson Coors Brewing Company (TAP) and they all pay dividends with yields ranging from just 0.9% for Anheuser Busch to 8.4% for Altria and average out at 3.1%.
  4. The Canadian Cannabis LPs Index; UP 0.1% last week; UP 15.9% YTD
    • The Index consists of the 5 largest Canadian Licensed Producers, namely: Aurora (ACB); Canopy Growth (CGC); Cronos (CRON); Organigram (OGI), and Tilray (TLRY) which trade for at least US$1/share on the Canadian and/or American stock exchanges and have a market cap in excess of US$250M.
    • Read: 5 Largest Canadian Cannabis Stocks Flat This Week
  5. The Psychedelic Drug Stocks Index: DOWN 2.9% last week; UP 12.8% YTD
    • The Index consists of 6 psychedelic compound-based and marijuana (THC) drug companies in the clinical stages of research and development of treatments for a wide variety of mental illnesses, namely, Cybin (CYBN); Atai (ATAI); Seelos (SEEL), Compass Pathway (CMPS); Mind Medicine (MNMD) and GH Resources (GHRS) which trade on the Canadian and/or American stock exchanges and have market caps of at least US$50M.
    • Read; 6 Largest Psychedelic Stocks Down 3% This Week

In summary, the 5 cannabis/cannabis-related company stock category performances ranged from:

  • +12.0% to -2.9% last week,  and are now
  • +16.8% to +0.1% YTD.

More By This Author:

12 Largest American Cannabis MSO Stocks Up 7% This Week
5 Largest Canadian Cannabis Stocks Flat This Week
A Comparison Of 7 Cannabis Portfolio Performances YTD And Last Week

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample here).

Comments